We are live on ! Find out more
Sachetta

Sachetta Portfolio holdings

AUM $206M Turnover 30.12%
1-Year Est. Return 26.19%
This Fund
S&P 500
This Quarter Est. Return
+13.87%
1 Year Est. Return
+26.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$21.3M
Cap. Flow
+$2.73M
Cap. Flow %
1.33%
Top 10 Hldgs %
51.79%
Holding
1,235
New
162
Increased
525
Reduced
190
Closed
210
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 75.75%
2 Technology 9.61%
3 Financials 3.79%
4 Healthcare 2.43%
5 Consumer Discretionary 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CPT icon
876
Camden Property Trust
CPT
$11.6B
$1.14K ﹤0.01%
10
– –
2023 Q4
10 quarters
IDCC icon
877
InterDigital
IDCC
$7.57B
$1.13K ﹤0.01%
+4
New +$1.19K
2026 Q2
0 quarters
SMG icon
878
ScottsMiracle-Gro
SMG
$3.86B
$1.09K ﹤0.01%
16
-8
-33% -$495
2023 Q4
10 quarters
OGN icon
879
Organon & Co
OGN
$3.64B
$1.08K ﹤0.01%
80
– –
2023 Q4
10 quarters
ADC icon
880
Agree Realty
ADC
$9.13B
$1.06K ﹤0.01%
14
-8
-36% -$606
2023 Q4
10 quarters
IDA icon
881
Idacorp
IDA
$8.64B
$1.06K ﹤0.01%
7
-9
-56% -$1.3K
2026 Q1
1 quarter
QS icon
882
QuantumScape Corp
QS
$2.83B
$1.06K ﹤0.01%
140
– –
2024 Q4
6 quarters
SR icon
883
Spire
SR
$5.25B
$1.05K ﹤0.01%
+15
New +$1.29K
2026 Q2
0 quarters
CORT icon
884
Corcept Therapeutics
CORT
$8.11B
$1.04K ﹤0.01%
+12
New +$725
2026 Q2
0 quarters
BMRN icon
885
BioMarin Pharmaceuticals
BMRN
$11.1B
$1.03K ﹤0.01%
+18
New +$986
2026 Q2
0 quarters
FHYS icon
886
Federated Hermes Short Duration High Yield ETF
FHYS
$72.7M
$1K ﹤0.01%
+43
New +$995
2026 Q2
0 quarters
AMCR icon
887
Amcor
AMCR
$20.8B
$998 ﹤0.01%
+23
New +$913
2026 Q2
0 quarters
AAP icon
888
Advance Auto Parts
AAP
$2.77B
$996 ﹤0.01%
16
– –
2025 Q2
4 quarters
ITT icon
889
ITT
ITT
$19.5B
$989 ﹤0.01%
5
– –
2023 Q4
10 quarters
AM icon
890
Antero Midstream
AM
$9.23B
$979 ﹤0.01%
43
– –
2023 Q4
10 quarters
ENB icon
891
Enbridge
ENB
$106B
$975 ﹤0.01%
18
– –
2026 Q1
1 quarter
ARMK icon
892
Aramark
ARMK
$14.4B
$968 ﹤0.01%
+17
New +$839
2026 Q2
0 quarters
INSM icon
893
Insmed
INSM
$25.5B
$960 ﹤0.01%
9
-33
-79% -$4K
2025 Q3
3 quarters
CART icon
894
Maplebear
CART
$13.8B
$947 ﹤0.01%
+20
New +$836
2026 Q2
0 quarters
RARE icon
895
Ultragenyx Pharmaceutical
RARE
$1.67B
$935 ﹤0.01%
+28
New +$695
2026 Q2
0 quarters
GPC icon
896
Genuine Parts
GPC
$17.3B
$927 ﹤0.01%
8
-13
-62% -$1.36K
2023 Q4
10 quarters
SCI icon
897
Service Corp International
SCI
$9.9B
$912 ﹤0.01%
12
-22
-65% -$1.72K
2023 Q4
10 quarters
RVTY icon
898
Revvity
RVTY
$17.9B
$891 ﹤0.01%
8
– –
2023 Q4
10 quarters
CUBE icon
899
CubeSmart
CUBE
$10.1B
$875 ﹤0.01%
22
– –
2023 Q4
10 quarters
JBTM icon
900
JBT Marel
JBTM
$6.61B
$870 ﹤0.01%
6
– –
2023 Q4
10 quarters

Similar funds

Sachetta's Q2 2026 Portfolio in Review

As of Q2 2026, Sachetta held 1,235 positions worth $206M, up 12% from $184M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sachetta's Q2 2026 filing shows 162 new, 525 increased, 190 reduced and 210 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 2,568 shares worth $422K. The largest sale was iShares Russell 1000 ETF, an estimated $5.96M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 79% a quarter earlier, followed by Technology and Financials.

  • Sachetta's largest Q2 2026 buy was iShares Core S&P Total US Stock Market ETF: 2,568 shares worth $422K.
  • Sachetta added most to Teradyne in Q2 2026, an estimated $5.76M increase.
  • Sachetta's biggest Q2 2026 reduction was Xtrackers MSCI Emerging Markets Hedged Equity ETF, cutting an estimated $233K.
  • Sachetta fully exited iShares Russell 1000 ETF in Q2 2026, selling an estimated $5.96M.
  • Sachetta's ten largest holdings make up 52% of its $206M portfolio in Q2 2026.
  • Sachetta opened 162 new positions and closed 210 in Q2 2026.
  • Sachetta's portfolio value rose 12% quarter-over-quarter to $206M.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.